[HTML][HTML] Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis

P Savola, T Kelkka, HL Rajala, A Kuuliala… - Nature …, 2017 - nature.com
P Savola, T Kelkka, HL Rajala, A Kuuliala, K Kuuliala, S Eldfors, P Ellonen, S Lagström
Nature communications, 2017nature.com
Somatic mutations contribute to tumorigenesis. Although these mutations occur in all
proliferating cells, their accumulation under non-malignant conditions, such as in
autoimmune disorders, has not been investigated. Here, we show that patients with newly
diagnosed rheumatoid arthritis have expanded CD8+ T-cell clones; in 20%(5/25) of patients
CD8+ T cells, but not CD4+ T cells, harbour somatic mutations. In healthy controls (n= 20),
only one mutation is identified in the CD8+ T-cell pool. Mutations exist exclusively in the …
Abstract
Somatic mutations contribute to tumorigenesis. Although these mutations occur in all proliferating cells, their accumulation under non-malignant conditions, such as in autoimmune disorders, has not been investigated. Here, we show that patients with newly diagnosed rheumatoid arthritis have expanded CD8+ T-cell clones; in 20% (5/25) of patients CD8+ T cells, but not CD4+ T cells, harbour somatic mutations. In healthy controls (n=20), only one mutation is identified in the CD8+ T-cell pool. Mutations exist exclusively in the expanded CD8+ effector-memory subset, persist during follow-up, and are predicted to change protein functions. Some of the mutated genes (SLAMF6, IRF1) have previously been associated with autoimmunity. RNA sequencing of mutation-harbouring cells shows signatures corresponding to cell proliferation. Our data provide evidence of accumulation of somatic mutations in expanded CD8+ T cells, which may have pathogenic significance for RA and other autoimmune diseases.
nature.com